About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Report Type
Organization
Disposition
Year
Month
Found 63701 record(s)
Req # A-2023-001047
A Health Canada Compliance and Enforcement Inspection Report on the Cannabis Industry reported, for 2018-19, 32 referrals from Health Canada to the Royal Canadian Mounted Police (RCMP) for action. The names of the 32 companies and/or promotions events that were referred to the RCMP; Reasons for the referrals to the RCMP; Dates of the 32 referrals to the RCMP and identification of which RCMP detachments the referral went to; Correspondence between Health Canada and RCMP related to these referrals; Current status or outcomes of the referrals to the RCMP, if the RCMP has already communicated these to Health Canada.Organization: Health Canada
February 2024
Req # A-2023-001083
Information regarding product name, dosage form and strength of Carbidopa, levodopa generic submissions under review. This product listed under Generic Submissions Under Review list dated 2023-10-19.Organization: Health Canada
February 2024
Req # A-2023-001153
A report/speadsheet showing the total number of consultant hired and all corresponding costs, broken down by department/agency and calendar year (2015 - 2023).Organization: Health Canada
February 2024
Req # A-2023-001158
All information included in the submission and review of Natural Product Number (NPN) 80059723 Berberine/Berberine 500 mg.Organization: Health Canada
February 2024
Req # A-2023-001188
A line listing in the Canada Vigilance Database of adverse reaction reports involving "copycat" edible cannabis products. Case reports made between the dates 01/01/2017 - 12/19/2023Organization: Health Canada
February 2024
Req # A-2023-001203
Research/studies Health Canada uses to base the decisions on warning Canadians for pregabalin/Lyrica.Organization: Health Canada
February 2024
Req # A-2023-001225
All Microsoft (MS) teams and email messages conveying instructions to let staff off early on December 22, 2023. The range of dates for this is 2023-12-21 to 2023-12-22.Organization: Health Canada
February 2024
Req # A-2023-001243
The number of applications for exemption under subsection 56(1) of the Controlled Drugs and Substances Act (CDSA) to possess and use psilocybin that were received by the Minister of Health in 2021, 2022 and 2023. The number of exemptions under subsection 56(1) of the Controlled Drugs and Substances Act (CDSA) to possess and use psilocybin that were issued by the Minister of Health in 2021, 2022 and 2023.Organization: Health Canada
February 2024
Req # A-2023-001244
The number of requests filed by medical practitioners on behalf of their patients to access psilocybin through Health Canada's Special Access Program (SAP) for emergency treatment of their patient in 2022, 2023, and 2024. The number of requests filed by medical practitioners on behalf of patients identifying as men and/or male to access psilocybin through Health Canada's Special Access Program (SAP) for emergency treatment of their patient in 2022, 2023, and 2024. The number of requests filed by medical practitioners on behalf of patients identifying as female and/or women to access psilocybin through Health Canada's Special Access Program (SAP) for emergency treatment of their patient in 2022, 2023, and 2024. The number of Special Access Program (SAP) requests filed by medical practitioners on behalf of their patients to access psilocybin for emergency treatment of their patient that were granted and/or approved in 2022, 2023, and 2024. The number of Special Access Program (SAP) requests filed by medical practitioners on behalf of patients identifying as men and/or male to access psilocybin for emergency treatment of their patient that were granted and/or approved in 2022, 2023, and 2024. The number of Special Access Program (SAP) requests filed by medical practitioners on behalf of patients identifying as female and/or women to access psilocybin for emergency treatment of their patient that were granted and/or approved in 2022, 2023, and 2024.Organization: Health Canada
February 2024
Req # A-2023-001249
All records mentioning “ribosomal frameshift”, “ribosomal frame shift”, “ribosomal frameshifting”, “ribosomal frame shifting”, “ribosomal frameshifts”, “ribosomal frame shifts”, in the context of Messenger Ribonucleic Acid (mRNA) vaccination since 2023-12-01.Organization: Health Canada
February 2024